vs
Anterix Inc.（ATEX）与DBV Technologies S.A.（DBVT）财务数据对比。点击上方公司名可切换其他公司
DBV Technologies S.A.的季度营收约是Anterix Inc.的1.8倍（$2.8M vs $1.6M），Anterix Inc.净利率更高（-419.6% vs -1195.5%，领先775.9%），DBV Technologies S.A.同比增速更快（158.8% vs 0.4%），Anterix Inc.自由现金流更多（$-8.3M vs $-32.6M），过去两年DBV Technologies S.A.的营收复合增速更高（12.4% vs 11.7%）
Anterix Inc.是总部位于美国的无线通信企业，持有合规900MHz频谱牌照，主要面向电力公用事业、公共安全机构、交通运营商等关键基础设施运营主体，提供安全专用的私有宽带网络解决方案，核心市场为北美，满足客户关键业务对高可靠连接的需求。
DBV Technologies是一家总部位于法国巴涅的公开上市生物制药企业，核心研发成果为Viaskin给药技术，可在不进入血液循环的前提下，让过敏原或抗原作用于完整皮肤。其花生过敏疗法Viaskin Peanut的临床开发，已获得美国食品药品监督管理局授予快速通道资格。
ATEX vs DBVT — 直观对比
营收规模更大
DBVT
是对方的1.8倍
$1.6M
营收增速更快
DBVT
高出158.3%
0.4%
净利率更高
ATEX
高出775.9%
-1195.5%
自由现金流更多
ATEX
多$24.3M
$-32.6M
两年增速更快
DBVT
近两年复合增速
11.7%
损益表 — Q3 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6M | $2.8M |
| 净利润 | $-6.6M | $-33.2M |
| 毛利率 | — | — |
| 营业利润率 | -576.0% | -1235.7% |
| 净利率 | -419.6% | -1195.5% |
| 营收同比 | 0.4% | 158.8% |
| 净利润同比 | -185.6% | -8.9% |
| 每股收益（稀释后） | $-0.35 | $-0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATEXDBVT
| Q4 25 | $1.6M | — | ||
| Q3 25 | $1.6M | $2.8M | ||
| Q2 25 | $1.4M | $1.5M | ||
| Q1 25 | $1.4M | — | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $1.6M | — | ||
| Q2 24 | $1.5M | $1.2M | ||
| Q1 24 | $1.3M | $1.4M |
净利润ATEXDBVT
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $53.5M | $-33.2M | ||
| Q2 25 | $25.2M | $-41.9M | ||
| Q1 25 | $9.2M | — | ||
| Q4 24 | $7.7M | — | ||
| Q3 24 | $-12.8M | — | ||
| Q2 24 | $-15.5M | $-33.1M | ||
| Q1 24 | $-9.4M | $-27.3M |
营业利润率ATEXDBVT
| Q4 25 | -576.0% | — | ||
| Q3 25 | — | -1235.7% | ||
| Q2 25 | — | -2806.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -846.6% | — | ||
| Q2 24 | -984.4% | -2914.9% | ||
| Q1 24 | -834.2% | -2029.7% |
净利率ATEXDBVT
| Q4 25 | -419.6% | — | ||
| Q3 25 | 3449.5% | -1195.5% | ||
| Q2 25 | 1775.7% | -2858.4% | ||
| Q1 25 | 662.9% | — | ||
| Q4 24 | 492.3% | — | ||
| Q3 24 | -823.1% | — | ||
| Q2 24 | -1018.0% | -2852.4% | ||
| Q1 24 | -746.9% | -1943.5% |
每股收益（稀释后）ATEXDBVT
| Q4 25 | $-0.35 | — | ||
| Q3 25 | $2.86 | $-0.24 | ||
| Q2 25 | $1.35 | $-0.31 | ||
| Q1 25 | $0.51 | — | ||
| Q4 24 | $0.41 | — | ||
| Q3 24 | $-0.69 | — | ||
| Q2 24 | $-0.84 | $-0.34 | ||
| Q1 24 | $-0.51 | $-0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.5M | $69.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $236.0M | $52.9M |
| 总资产 | $417.0M | $110.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATEXDBVT
| Q4 25 | $29.5M | — | ||
| Q3 25 | $39.1M | $69.8M | ||
| Q2 25 | $41.4M | $103.2M | ||
| Q1 25 | $47.4M | — | ||
| Q4 24 | $28.8M | — | ||
| Q3 24 | $43.1M | — | ||
| Q2 24 | $51.7M | $66.2M | ||
| Q1 24 | $60.6M | $101.5M |
股东权益ATEXDBVT
| Q4 25 | $236.0M | — | ||
| Q3 25 | $240.3M | $52.9M | ||
| Q2 25 | $184.8M | $86.2M | ||
| Q1 25 | $156.6M | — | ||
| Q4 24 | $144.7M | — | ||
| Q3 24 | $139.1M | — | ||
| Q2 24 | $148.8M | $79.1M | ||
| Q1 24 | $161.0M | $111.7M |
总资产ATEXDBVT
| Q4 25 | $417.0M | — | ||
| Q3 25 | $420.4M | $110.5M | ||
| Q2 25 | $359.6M | $143.4M | ||
| Q1 25 | $333.1M | — | ||
| Q4 24 | $326.7M | — | ||
| Q3 24 | $317.2M | — | ||
| Q2 24 | $321.1M | $114.2M | ||
| Q1 24 | $324.9M | $145.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.3M | $-32.4M |
| 自由现金流经营现金流 - 资本支出 | $-8.3M | $-32.6M |
| 自由现金流率自由现金流/营收 | -526.4% | -1173.5% |
| 资本支出强度资本支出/营收 | 0.6% | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-138.3M |
8季度趋势，按日历期对齐
经营现金流ATEXDBVT
| Q4 25 | $-8.3M | — | ||
| Q3 25 | $1.4M | $-32.4M | ||
| Q2 25 | $-3.1M | $-33.9M | ||
| Q1 25 | $-16.6M | — | ||
| Q4 24 | $-7.7M | — | ||
| Q3 24 | $-2.6M | — | ||
| Q2 24 | $-2.4M | $-35.1M | ||
| Q1 24 | $6.1M | $-34.7M |
自由现金流ATEXDBVT
| Q4 25 | $-8.3M | — | ||
| Q3 25 | — | $-32.6M | ||
| Q2 25 | — | $-33.9M | ||
| Q1 25 | $-16.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.7M | — | ||
| Q2 24 | — | $-35.8M | ||
| Q1 24 | $6.1M | $-36.0M |
自由现金流率ATEXDBVT
| Q4 25 | -526.4% | — | ||
| Q3 25 | — | -1173.5% | ||
| Q2 25 | — | -2316.5% | ||
| Q1 25 | -1195.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -173.4% | — | ||
| Q2 24 | — | -3084.0% | ||
| Q1 24 | 484.1% | -2560.6% |
资本支出强度ATEXDBVT
| Q4 25 | 0.6% | — | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 0.0% | 63.0% | ||
| Q1 24 | 3.2% | 94.9% |
现金转化率ATEXDBVT
| Q4 25 | — | — | ||
| Q3 25 | 0.03× | — | ||
| Q2 25 | -0.12× | — | ||
| Q1 25 | -1.80× | — | ||
| Q4 24 | -1.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
